LITERATURE REVIEW ON HOSPITAL COSTS FOR PATIENTS UNDERGOING HYSTERECTOMY
Author(s)
Chen BP1, Cheng H2, Romney M3, Hsiao C4
1Ethicon Inc., Somerville, NJ, USA, 2Global Health Economics and Market Access, Ethicon Inc., Cincinnati, OH, USA, 3Jefferson School of Population Health, Philadelphia, PA, USA, 4Ethicon Inc., Cincinnati, OH, USA
OBJECTIVES: This study aims to identify the range of direct hospital costs associated with a minimally invasive or open hysterectomy procedure across different countries. METHODS: A PubMed search was performed using the keywords: hysterectomy [MeSH] and cost/economic/comparison with results limited to publications of human subject studies in English from 2006 to November 2015. Studies comparing minimally invasive surgical techniques (laparoscopic or laparoscopic-assisted) to open surgical techniques were selected and studies of comparisons other than minimally invasive versus open procedures (e.g. robotic or vaginal) were excluded. All abstracts were filtered, including meta-analysis, RCTs and observational studies excluding case studies. RESULTS: Thirty-one of 89 articles were included in the analysis. Fourteen (45%) studies were conducted in North America with the remaining based in European and Asian-Pacific countries. Direct hospital costs varied dramatically across countries. In North America, the cost of operating rooms (minute) ranged from $8-$10 for open procedures and $7-$9 for laparoscopies. The anesthesia cost (minute) ranged from $7-$11 and the cost for hospital stay (day) ranged from $215-$777 regardless of procedure type. In European countries, the cost of operating rooms (minute) ranged from $8-$26 for open procedures and around $12 for laparoscopy. The cost for hospital stay (day) ranged from $407-$1036. In Asia, the cost of operating rooms (minute) ranged from $5-$7 for open procedures and $8-$9 for laparoscopies. CONCLUSIONS: European countries have reported higher direct hospital costs. The evidence in addition to perioperative outcomes regarding direct hospital costs in Asian-Pacific countries is relatively limited. Comparison of direct hospital costs is challenging due to different costing structures and variations in reimbursement and clinical practices across countries. A standardized costing methodology guideline is warranted and may shed light on the future considerations of reimbursement strategy.
Conference/Value in Health Info
2016-05, ISPOR 2016, Washington DC, USA
Value in Health, Vol. 19, No. 3 (May 2016)
Code
PIH21
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Oncology, Reproductive and Sexual Health